1-5 of 5
Christina Kong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B021: FTO inhibition enhances the therapeutic index of radiation therapy in head and neck cancer

Free
Lu Ji, Leighton Pu, Hongbin Cao, Stavros Melemenidis, Subarna Sinha, Li Guan, Eyiwunmi E. Laseinde, Sara Richter, Rie Eyben, Kerriann M. Casey, Christina Kong, Edward Graves, Quynh-Thu Le, Erinn Rankin
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (2_Supplement): B021.
https://doi.org/10.1158/1557-3265.TARGETEDTHERAP-B021
Published: 26 January 2025
View articletitled, Abstract B021: FTO inhibition enhances the therapeutic index of radiation therapy in head and neck cancer
Journal Articles

Abstract PO-066: Relationship between KEAP1/NFE2L2 pathway activation and radiation resistance in oral cavity cancer

Free
Li Guan, Hongbin Cao, Angela Hui, Shirley Kwok, Vignesh Viswanathan, Dhanya Nambiar, Rie V. Eyben, Brittany Holmes, Christina Kong, Maximilian Diehn, Quynh-Thu Le
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-066.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-066
Published: 15 April 2021
View articletitled, Abstract PO-066: Relationship between KEAP1/NFE2L2 pathway activation and radiation resistance in oral cavity cancer
Journal Articles

Abstract 62: Loss of PERP p53/p63 target gene may indicate tumorigenesis at the margin and local recurrence

Free
Amanda Simmons, Christina Kong, Rie von Eyben, Laura Attardi, Xiaohui Ma, Quynh-Thu Le, Cherie-Ann Nathan
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (23_Supplement): 62.
https://doi.org/10.1158/1557-3265.AACRAHNS17-62
Published: 30 November 2017
View articletitled, Abstract 62: Loss of PERP p53/p63 target gene may indicate tumorigenesis at the margin and local recurrence
Journal Articles

Nanoscale approaches to define biologic signatures and measure proteomic response to targeted therapies in hematologic and solid tumors

Free
Alice C. Fan, Jessica L. Dermody, Christina Kong, Nancy Zhang, Liwen Xu, John P. Renschler, Mathias W. Orban, Ben Varasteh, Kunju Sridhar, Yasodha Natkunam, Stephen E. Coutre, Peter Greenberg, Dean W. Felsher
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19_Supplement): PR6.
https://doi.org/10.1158/DIAG-10-PR6
Published: 15 August 2014
View articletitled, Nanoscale approaches to define biologic signatures and measure proteomic response to targeted therapies in hematologic and solid tumors
Journal Articles

Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer

Available to Purchase
Quynh-Thu Le, Richard Fisher, Kelly S. Oliner, Richard J. Young, Hongbin Cao, Christina Kong, Edward Graves, Rodney J. Hicks, Grant A. McArthur, Lester Peters, Brian O'Sullivan, Amato Giaccia, Danny Rischin
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1798–1807.
https://doi.org/10.1158/1078-0432.CCR-11-2094
Published: 14 March 2012
View articletitled, Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer
Open the PDF for Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer in another window
Includes: Supplementary data